Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
International
Growing Like Weeds- MedTech Europe Adopts New Code of Ethical Business…
MedTech Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the…
Novartis Korea in Kickback Investigation – Medical Journal Rebates
In a recent securities filing, Novartis alluded to future issues for the Swiss company. In their Interim Financial…
UK’s Version of EFPIA Disclosure: Bred with the Sunshine Act in Mind
Recently, we wrote about the transparency and disclosure changes coming to Europe, and promised a more in-depth view of…
EFPIA Disclosure “Sunshine Act – Lite”
For the first time, on June 30, 2016, pharmaceutical companies will be forced to disclose full data on payments made to…
Physician Payment Sunshine: Canadian Style
According to a report, 10 Canadian-based firms have agreed to divulge the amount of money they give to physicians and…
Novartis Settles China Foreign Corrupt Practices Complaint
Novartis AG has settled civil charges against the company, for $25 million to the United States Securities and Exchange…
New Canadian CME Standards for Commercial Support
Canada has created new standards for industry involvement with accredited CME programs. Three professional…
European Medicines Agency: Framework for Interaction with Industry
The European Medicines Agency's (EMA) Management Board has adopted a new framework to govern interaction between the…
The College of Family Physicians of Canada and Commercial Support for CME
Once again, the fact that the pharmaceutical industry helps financially support continuing medical education programs is…
EDMA and Eucomed Adopt Code of Business Practice Brings Changes to Medical…
Members of both the European Diagnostic Manufacturers Association (EDMA) and the European Medical Technology Industry…